Literature DB >> 26493810

Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres.

Akihiko Seki1, Shinichi Hori2, Chigusa Shimono3.   

Abstract

PURPOSE: Contrast material pooling on angiography within a tumor bed during embolization for hepatocellular carcinoma (HCC) presents as the vascular lake (VL) phenomenon. This retrospective study aimed to evaluate the frequency and management of VLs during chemoembolization with drug-eluting beads (DEBs) and the relationship between the VL and local response.
MATERIALS AND METHODS: A total of 123 HCC patients without vascular invasion or intrahepatic metastases who underwent chemoembolization with DEBs (50-100 µm superabsorbent polymer microspheres loaded with epirubicin) were enrolled. Gelatin sponge particles (GS) were injected for additional embolization in limited patients with steadily increasing size of VLs during DEB injection. Overall, 338 nodules were divided into three groups: lesions without a VL (non-VL; n = 250); lesions with a VL but without additional GS embolization [VL-GS (-), n = 58]; and lesions with both VL and additional GS embolization [VL-GS (+); n = 30]. The local responses were statistically compared by Fisher's exact test with the Bonferroni correction.
RESULTS: The frequency of VLs was 26.0% (88/338). The response rate in the non-VL group (54.0%) was significantly lower than those in the VL-GS (-) (91.4%; P < 0.0001) and VL-GS (+) (96.7%; P < 0.0001) groups.
CONCLUSIONS: VL is a common angiographic finding and might be associated with the local response.

Entities:  

Keywords:  Chemoembolization; Hepatocellular carcinoma; Local response; Microspheres; Vascular lake

Mesh:

Substances:

Year:  2015        PMID: 26493810     DOI: 10.1007/s11604-015-0486-2

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  12 in total

1.  Transcatheter arterial embolization with spherical embolic agent for pulmonary metastases from renal cell carcinoma.

Authors:  Akihiko Seki; Shinichi Hori; Satoru Sueyoshi; Atsushi Hori; Michihiko Kono; Shinichi Murata; Masahiko Maeda
Journal:  Cardiovasc Intervent Radiol       Date:  2013-02-21       Impact factor: 2.740

Review 2.  Hepatic embolotherapy in interventional oncology: technology, techniques, and applications.

Authors:  J Kritzinger; D Klass; S Ho; H Lim; A Buczkowski; E Yoshida; D Liu
Journal:  Clin Radiol       Date:  2012-08-20       Impact factor: 2.350

3.  Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.

Authors:  J Yamanaka; N Yamanaka; K Nakasho; T Tanaka; T Ando; C Yasui; N Kuroda; M Takata; S Maeda; K Matsushita; K Uematsu; E Okamoto
Journal:  J Gastroenterol Hepatol       Date:  2000-10       Impact factor: 4.029

Review 4.  Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

5.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

Authors:  Josep M Llovet; Maria Isabel Real; Xavier Montaña; Ramon Planas; Susana Coll; John Aponte; Carmen Ayuso; Margarita Sala; Jordi Muchart; Ricard Solà; Joan Rodés; Jordi Bruix
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

6.  Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience.

Authors:  Akihiko Seki; Shinich Hori; Kazuya Kobayashi; Seizi Narumiya
Journal:  Cardiovasc Intervent Radiol       Date:  2010-09-07       Impact factor: 2.740

Review 7.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

8.  Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.

Authors:  Keigo Osuga; Shinichi Hori; Kumiko Hiraishi; Takashi Sugiura; Yasuhiro Hata; Hiroki Higashihara; Noboru Maeda; Kaname Tomoda; Hironobu Nakamura
Journal:  Cardiovasc Intervent Radiol       Date:  2008-06-10       Impact factor: 2.740

9.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

10.  Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study.

Authors:  Katerina Malagari; Maria Pomoni; Hippokratis Moschouris; Alexios Kelekis; Angelos Charokopakis; Evanthia Bouma; Themistoklis Spyridopoulos; Achilles Chatziioannou; Vlasios Sotirchos; Theodoros Karampelas; Constantin Tamvakopoulos; Dimitrios Filippiadis; Enangelos Karagiannis; Athanasios Marinis; John Koskinas; Dimitrios A Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2013-11-22       Impact factor: 2.740

View more
  11 in total

1.  Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment.

Authors:  Pi-Yi Chang; Chun-Chieh Huang; Chao-Hung Hung; Chih-Yung Yu; Ding-Kwo Wu; Jen-I Hwang; Po-Chin Liang; Reng-Hong Wu; Wei-Lun Tsai; Yih-Jyh Lin; Yi-Sheng Liu; Huei-Lung Liang; Rheun-Chuan Lee; Chien-Hung Chen
Journal:  Liver Cancer       Date:  2018-03-29       Impact factor: 11.740

Review 2.  Cerebral lipiodol embolism related to a vascular lake during chemoembolization in hepatocellular carcinoma: A case report and review of the literature.

Authors:  Hideki Ishimaru; Minoru Morikawa; Takayuki Sakugawa; Ichiro Sakamoto; Yasuhide Motoyoshi; Yohei Ikebe; Masataka Uetani
Journal:  World J Gastroenterol       Date:  2018-10-07       Impact factor: 5.742

3.  Balloon-Occluded Trans-Arterial Chemo-Embolization Technique with Repeated Alternate Infusion of Cisplatin Solution and Sparse Gelatin Slurry (RAIB-TACE) for Large Hepatocellular Carcinoma Nodules More than 7 cm in Diameter.

Authors:  Toshiyuki Irie; Nobuyuki Takahashi; Toshiro Kamoshida; Junya Kashimura; Hiroyuki Ariga
Journal:  Biomed Res Int       Date:  2020-01-19       Impact factor: 3.411

4.  Imaging features and outcomes in patients with ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization: a retrospective clinical study.

Authors:  Wenpeng Zhao; Xiaopu Hou; Honglu Li; Jiang Guo; Liang Cai; Youjia Duan; Hongliu Du; Xihong Shao; Zhenying Diao; Changqing Li
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

5.  Occurrence, Related Factors and Prognostic Value of Vascular Lake in Hepatocellular Carcinoma Patients Treated with Drug-Eluting Bead Transarterial Chemoembolization.

Authors:  Hao Li; Manzhou Wang; Pengfei Chen; Fangzheng Li; Donglin Kuang; Xinwei Han; Jianzhuang Ren; Xuhua Duan
Journal:  Onco Targets Ther       Date:  2021-08-31       Impact factor: 4.147

6.  Portal Vein Damage after DEB-TACE and Lipiodol-TACE: Based on Evaluation by Computed Tomography during Arterial Portography.

Authors:  Masashi Tamura; Seishi Nakatsuka; Hideyuki Torikai; Manabu Misu; Jitsuro Tsukada; Kentaro Tamura; Nobutake Ito; Masanori Inoue; Hideki Yashiro; Masahiro Jinzaki
Journal:  Interv Radiol (Higashimatsuyama)       Date:  2021-11-01

7.  Vascular Lake Phenomenon.

Authors:  Akira Kuriyama; Etsuro Sakata; Tomohiko Sunami
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

8.  Predictive imaging for tumor response to drug-eluting microsphere transarterial chemoembolization in patients with BCLC-C advanced hepatocellular carcinoma.

Authors:  Kai-Hsiang Chang; Zhen-An Hwang; Ping-Ying Chang; Hsuan-Hwai Lin; Yu-Lueng Shih; Wei-Chou Chang; Guo-Shu Huang; Hsian-He Hsu
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

9.  Clinical management of vascular lake during transarterial chemoembolization with CalliSpheres drug-eluting beads (DEBs) for the treatment of hepatocellular carcinoma.

Authors:  Jian Kong; Xiongying Jiang; Yanfang Zhang; Weidong Wang; Yong Li; Xinying Shen; Jianxi Guo; Hongliang Sun; Dong Chen; Yaoting Chen; Linfeng Xu
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

10.  Prospective Multi-Center Korean Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolics for Nodular Hepatocellular Carcinoma: A Two-Year Outcome Analysis.

Authors:  Myungsu Lee; Jin Wook Chung; Kwang-Hun Lee; Jong Yun Won; Ho Jong Chun; Han Chu Lee; Jin Hyoung Kim; In Joon Lee; Saebeom Hur; Hyo-Cheol Kim; Yoon Jun Kim; Gyoung Min Kim; Seung-Moon Joo; Jung Suk Oh
Journal:  Korean J Radiol       Date:  2021-06-01       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.